Why is Ishita Drugs falling/rising?

As of 24-Sep, Ishita Drugs & Industries Ltd is experiencing a price increase, currently at Rs 83.00, reflecting a rise of 2.14 (2.65%). The stock has shown strong performance recently, outperforming its sector by 3.1% today and achieving a consecutive gain over the last two days with a total return of 3.75%. It has also traded above its moving averages across various time frames, indicating positive momentum. Additionally, the company reported positive financial results for the nine-month period, with net sales and profit after tax both higher than previous periods, and a favorable PEG ratio of 0.7 suggests attractive valuation compared to peers.
In the broader market context, Ishita Drugs has outperformed the benchmark Sensex, which has seen a decline of 1.18% over the past week, while the stock itself has risen by 5.80%. Despite a negative return of -10.20% year-to-date, the stock's ability to generate an 8.00% return over the past year, while the broader BSE500 index has declined by -5.32%, highlights its resilience. However, it is important to note that there are concerns regarding the company's long-term fundamental strength, including a weak return on equity and slow growth in net sales, which could impact future performance.